{"id":"https://openalex.org/W4384466716","doi":"https://doi.org/10.1002/pbc.30559","title":"Position paper: The time for cooperative group study of ropeginterferon alfa\u20102b in young patients with myeloproliferative neoplasms is now","display_name":"Position paper: The time for cooperative group study of ropeginterferon alfa\u20102b in young patients with myeloproliferative neoplasms is now","publication_year":2023,"publication_date":"2023-07-16","ids":{"openalex":"https://openalex.org/W4384466716","doi":"https://doi.org/10.1002/pbc.30559","pmid":"https://pubmed.ncbi.nlm.nih.gov/37455243"},"language":"en","primary_location":{"id":"doi:10.1002/pbc.30559","doi":"https://doi.org/10.1002/pbc.30559","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pbc.30559","pdf_url":null,"source":{"id":"https://openalex.org/S119714264","display_name":"Pediatric Blood & Cancer","issn_l":"1545-5009","issn":["1545-5009","1545-5017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pediatric Blood & Cancer","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003759796","display_name":"Nicole Kucine","orcid":"https://orcid.org/0000-0002-4865-4033","observed_orcids":["https://orcid.org/0000-0002-4865-4033"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Nicole Kucine","raw_affiliation_strings":["Department of Pediatrics, Weill Cornell Medicine, New York, New York, USA"],"raw_orcid":"https://orcid.org/0000-0002-4865-4033","affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Weill Cornell Medicine, New York, New York, USA","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089293982","display_name":"Jewell A. Jessup","orcid":"https://orcid.org/0009-0002-4335-8427","observed_orcids":["https://orcid.org/0009-0002-4335-8427"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jewell A. Jessup","raw_affiliation_strings":["PharmaEssentia is in Burlington MA, PharmaEssentia USA Corporation, Burlington, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PharmaEssentia is in Burlington MA, PharmaEssentia USA Corporation, Burlington, Massachusetts, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038841996","display_name":"Todd M. Cooper","orcid":"https://orcid.org/0000-0002-1203-2371","observed_orcids":["https://orcid.org/0000-0002-1203-2371"]},"institutions":[{"id":"https://openalex.org/I1295499534","display_name":"Seattle Children's Hospital","ror":"https://ror.org/01njes783","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295499534"]},{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Todd M. Cooper","raw_affiliation_strings":["Cancer and Blood Disorders Center, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer and Blood Disorders Center, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA","institution_ids":["https://openalex.org/I1295499534","https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110079802","display_name":"Raymond W. Urbanski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ray W. Urbanski","raw_affiliation_strings":["PharmaEssentia is in Burlington MA, PharmaEssentia USA Corporation, Burlington, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PharmaEssentia is in Burlington MA, PharmaEssentia USA Corporation, Burlington, Massachusetts, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009981843","display_name":"Edward Anders Kolb","orcid":"https://orcid.org/0000-0003-2854-9014","observed_orcids":["https://orcid.org/0000-0003-2854-9014"]},"institutions":[{"id":"https://openalex.org/I4210162262","display_name":"Blood Cancer United","ror":"https://ror.org/04m0xav37","country_code":"US","type":"other","lineage":["https://openalex.org/I4210162262"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E. Anders Kolb","raw_affiliation_strings":["The Leukemia & Lymphoma Society Rye Brook New York USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Leukemia & Lymphoma Society Rye Brook New York USA","institution_ids":["https://openalex.org/I4210162262"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061685890","display_name":"Linda M S Resar","orcid":"https://orcid.org/0000-0002-4004-7060","observed_orcids":["https://orcid.org/0000-0002-4004-7060"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Linda M. S. Resar","raw_affiliation_strings":["Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5003759796"],"corresponding_institution_ids":["https://openalex.org/I4387153466"],"apc_list":{"value":4330,"currency":"USD","value_usd":4330},"apc_paid":null,"fwci":0.8625,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.71631982,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":98},"biblio":{"volume":"70","issue":"10","first_page":"e30559","last_page":"e30559"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11616","display_name":"Autoimmune and Inflammatory Disorders Research","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ropeginterferon-alfa-2b","display_name":"ropeginterferon alfa-2b","score":0.9810000061988831},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.9909999966621399},{"id":"https://openalex.org/keywords/pediatric-patients","display_name":"pediatric patients","score":0.8259999752044678},{"id":"https://openalex.org/keywords/clinical-trial-design","display_name":"clinical trial design","score":0.5609999895095825},{"id":"https://openalex.org/keywords/interferon-therapy","display_name":"interferon therapy","score":0.5019999742507935}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8390886187553406},{"id":"https://openalex.org/C198082294","wikidata":"https://www.wikidata.org/wiki/Q3399648","display_name":"Position (finance)","level":2,"score":0.5116491913795471},{"id":"https://openalex.org/C2779965156","wikidata":"https://www.wikidata.org/wiki/Q5227350","display_name":"Data sharing","level":3,"score":0.468107670545578},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.4438607692718506},{"id":"https://openalex.org/C2781311116","wikidata":"https://www.wikidata.org/wiki/Q83306","display_name":"Group (periodic table)","level":2,"score":0.4318375885486603},{"id":"https://openalex.org/C78780964","wikidata":"https://www.wikidata.org/wiki/Q7233193","display_name":"Position paper","level":2,"score":0.4243050515651703},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3355974555015564},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.2247627079486847},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.17494606971740723},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/pbc.30559","doi":"https://doi.org/10.1002/pbc.30559","is_oa":false,"landing_page_url":"https://doi.org/10.1002/pbc.30559","pdf_url":null,"source":{"id":"https://openalex.org/S119714264","display_name":"Pediatric Blood & Cancer","issn_l":"1545-5009","issn":["1545-5009","1545-5017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pediatric Blood & Cancer","raw_type":"journal-article"},{"id":"pmid:37455243","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37455243","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pediatric blood & cancer","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.46000000834465027,"display_name":"Partnerships for the goals","id":"https://metadata.un.org/sdg/17"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W2761473139","https://openalex.org/W2767250221","https://openalex.org/W2769637064","https://openalex.org/W2889194299","https://openalex.org/W2895546171","https://openalex.org/W2977292756","https://openalex.org/W3003423609","https://openalex.org/W3011923330","https://openalex.org/W3096269688","https://openalex.org/W3117992776","https://openalex.org/W3133781817","https://openalex.org/W3158478185","https://openalex.org/W3204551178","https://openalex.org/W4205211254","https://openalex.org/W4206959743","https://openalex.org/W4213412710","https://openalex.org/W4229365888","https://openalex.org/W4283448665","https://openalex.org/W4284967461","https://openalex.org/W4316928320","https://openalex.org/W4362455313"],"related_works":["https://openalex.org/W4317433494","https://openalex.org/W3042765988","https://openalex.org/W4310093727","https://openalex.org/W4389887958","https://openalex.org/W4389692953","https://openalex.org/W4386282327","https://openalex.org/W4310093707","https://openalex.org/W7204708451","https://openalex.org/W7214068089","https://openalex.org/W4408070472"],"abstract_inverted_index":{"NK":[0],"is":[1,18,33],"a":[2,19],"consultant":[3,20],"for":[4,21],"Protagonist":[5],"Therapeutics":[6],"Inc.":[7],"and":[8,11,26],"PharmaEssentia.":[9,16],"JJ":[10],"RU":[12],"are":[13],"employees":[14],"of":[15],"TC":[17],"Day":[22],"One":[23],"Biopharmaceuticals.":[24],"AK":[25],"LMSR":[27],"have":[28],"no":[29,40],"conflicts.":[30],"Data":[31],"sharing":[32],"not":[34],"applicable":[35],"to":[36],"this":[37,48],"article":[38],"as":[39],"new":[41],"data":[42],"were":[43],"created":[44],"or":[45],"analyzed":[46],"in":[47],"study.":[49]},"counts_by_year":[{"year":2025,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-07-17T00:00:00"}